Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationships Between Test Results for Oral Hypofunction, Subjective Frailty Symptoms and Oral Health-Related Quality of Life of Japanese Dental Outpatients: A Multicentre, Cross-Sectional Study.
Morinaga D, Itoh T, Soejima Y, Horikawa T, Nagai S, Takeshita F, Abe N, Kaku T, Iijima T, Soejima D, Hara T, Sato R, Murakami M, Sawase T, Nishimura M. Morinaga D, et al. Among authors: nagai s. J Oral Rehabil. 2024 Dec;51(12):2634-2642. doi: 10.1111/joor.13858. Epub 2024 Sep 20. J Oral Rehabil. 2024. PMID: 39305030
Effects of various prosthetic methods for patients with Kennedy Class I partial edentulism on oral hypofunction, subjective symptoms, and oral health-related quality of life.
Morinaga D, Nagai S, Kaku T, Itoh T, Soejima Y, Takeshita F, Horikawa T, Abe N, Iijima T, Soejima D, Hara T, Sato R, Murakami M, Sawase T, Nishimura M. Morinaga D, et al. Among authors: nagai s. Int J Implant Dent. 2024 Jun 27;10(1):33. doi: 10.1186/s40729-024-00555-w. Int J Implant Dent. 2024. PMID: 38935335 Free PMC article.
Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: A multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study).
Takahashi A, Nomoto H, Yokoyama H, Yokozeki K, Furusawa S, Oe Y, Kameda R, Kawata S, Miyoshi A, Nagai S, Miya A, Kameda H, Nakamura A, Atsumi T; MEGMI study group. Takahashi A, et al. Among authors: nagai s. Diabetes Obes Metab. 2024 Dec 26. doi: 10.1111/dom.16150. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39726204
1,458 results